Daiichi, Mylan Push High Court To Hear Apotex Drug IP Fight
Daiichi Sankyo and Mylan Pharmaceuticals again pressed the U.S. Supreme Court on Tuesday to decide whether Apotex Inc. can continue with its drug patent infringement lawsuit challenging Mylan's generic exclusivity for...To view the full article, register now.
Already a subscriber? Click here to view full article